| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Driving the CAR to the Bone Marrow Transplant Program
|
Dave, Hema
|
|
|
14 |
6 |
p. 561-569
|
article
|
| 2 |
Early Management of CML
|
Shanmuganathan, Naranie
|
|
|
14 |
6 |
p. 480-491
|
article
|
| 3 |
Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper
|
Loh, Kah Poh
|
|
|
14 |
6 |
p. 523-535
|
article
|
| 4 |
Mutation-Driven Therapy in MDS
|
Swoboda, David M.
|
|
|
14 |
6 |
p. 550-560
|
article
|
| 5 |
Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders
|
Shouse, Geoffrey
|
|
|
14 |
6 |
p. 570-576
|
article
|
| 6 |
The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS)
|
Steensma, David P.
|
|
|
14 |
6 |
p. 536-542
|
article
|
| 7 |
The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
|
Shanmuganathan, Naranie
|
|
|
14 |
6 |
p. 501-506
|
article
|
| 8 |
Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
|
Rabian, Florence
|
|
|
14 |
6 |
p. 492-500
|
article
|
| 9 |
Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
|
Rabian, Florence
|
|
|
14 |
6 |
p. 492-500
|
article
|
| 10 |
Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO
|
Kuykendall, Andrew T.
|
|
|
14 |
6 |
p. 543-549
|
article
|
| 11 |
Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice
|
Clark, Richard E.
|
|
|
14 |
6 |
p. 507-514
|
article
|
| 12 |
Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
|
Economides, Minas P.
|
|
|
14 |
6 |
p. 515-522
|
article
|
| 13 |
What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?
|
Gale, Robert Peter
|
|
|
14 |
6 |
p. 477-479
|
article
|
Journal description